The effect of 2-morpholino-5-phenyl-6H-1, 3, 4-thiadiazine hydrobromide on the change of hematological indices of rats with alloxan diabetes

 
PIIS102872210002394-8-1
DOI10.31857/S102872210002394-8
Publication type Article
Status Published
Authors
Affiliation: Ural Federal University named after the first President of Russia B.N. Yeltsin
Affiliation:
Institute of immunology and physiology of URO Russian Academy of Sciences
Institute of medical cellular technologies
Affiliation: Institute of immunology and physiology of URO Russian Academy of Sciences
Affiliation:
Institute of immunology and physiology of URO Russian Academy of Sciences
Ural Federal University named after the first President of Russia B.N. Yeltsin
Institute of medical cellular technologies
Affiliation: Ural Federal University named after the first President of Russia B.N. Yeltsin
Affiliation: Ural Federal University named after the first President of Russia B.N. Yeltsin
Affiliation: Ural Federal University named after the first President of Russia B.N. Yeltsin
Journal nameRossiiskii immunologicheskii zhurnal
EditionVolume 12 Issue 3
Pages276-280
Abstract

The article presents data on the eff ect of substituted 1, 3, 4-thiadiazine on the change in hematological parameters of rats with alloxan diabetes. It was found that the synthetic compound L-17 has the ability to correct hematological disorders in rats with alloxan diabetes.

Keywordsblood, alloxan diabetes, 2-morpholino-5-phenyl-6H-1,3,4-thiadiazine, hydrobromide (compound L-17)
Received23.11.2018
Publication date12.01.2019
Cite   Download pdf To download PDF you should sign in
Размещенный ниже текст является ознакомительной версией и может не соответствовать печатной

views: 1146

Readers community rating: votes 0

1. Volchegorskiy I. A., Tishevskaya N. V., Dementieva E. V. Antianemic eff ect of Reamberin in the acute period of alloxan diabetes in rats // Experimental and Clinical Pharmacology. 2008, 71, 6, 23-27

2. Danilova I. G., Gette I. F., Bulavintseva T. S. Method of modeling alloxan diabetes. Patent RF №2534411. 2014

3. Emelyanov V. V., Savateeva E. A., Sidorova L. P., Tseitler T. A., Bulavintseva T. S., Gette I. F., Danilova I. G., Maksimova N. E., Mochulskaya N. N., Chupakhin O. N., Chereshnev V. A. The correction of metabolic disorders in alloxan diabetes with 1,3,4-thiadiazine derivatives. Russian Immunological Journal, 2015, 9(18), 2(1), 487-489

4. Emelyanov V. V., Leontiev D. V., Ishchenko A. V., Bulavintseva T. S., Savateeva E. A., Danilova I. G. Atomic force microscopy of erythrocytes and metabolic disorders in experimental diabetes mellitus and its correction with lipoic acid // Biophysics. 2016. Т. 61. № 6. S. 922-926

5. Kazakov V. Ya., Postovskiy I. Ya. Syntheses and some reactions of 4-substituted thiosemicarbazides. Reports of the Science Academy of USSR, 1960, 134, 4, 824-827

6. Sidorova L. P., Perova N. M., Egorova L. G., Novikova A. P. Study of reactivity of 1,3,4-thiadiazines in acidic and alkaline media in the transformation into pyrazoles // Abstracts of the I all-Union conference on theoretical organic chemistry. Volgograd, 1991, 232

7. Chupakhin O. N., Sidorova L. P., Perova N. M. et al. 2-aminopropylmorpholine-5-aryl- 6H-1,3,4-thiadiazine, dihydrobromide and 2-aminopropylmorpholine- 4-arylthiazole, hydrobromide possessing antiplatelet eff ect. Patent RF №2456284. 2012.

8. Shestakova S. A., Stepanova R. P., Stepanian M. L., Cherniakova D. N. Structural changes in platelets in alloxan diabetes as parameters of their activation in the vascular bed and morphologic features // Tsitologiia. 1999. Vol. 41, № 2. Р. 122–131.

Система Orphus

Loading...
Up